FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment
Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...
Hosted on MSN1mon
Johnson & Johnson sues Cigna units for alleging draining funds intended for copays: report
Johnson & Johnson (NYSE ... According to the report, J&J added Cigna’s Express Scripts pharmacy benefits manager and specialty pharmacy Accredo as defendants in an amended lawsuit it filed ...